Related references
Note: Only part of the references are listed.Classical and noncanonical functions of miRNAs in cancers
Mihnea P. P. Dragomir et al.
TRENDS IN GENETICS (2022)
Updates to the drug-resistant mechanism of proteasome inhibitors in multiple myeloma
Yang Bai et al.
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY (2021)
SERS liquid biopsy: An emerging tool for medical diagnosis
Vlad Moisoiu et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2021)
LncRNA linc00312 suppresses radiotherapy resistance by targeting DNA-PKcs and impairing DNA damage repair in nasopharyngeal carcinoma
Zhen Guo et al.
CELL DEATH & DISEASE (2021)
miR-126-3p contributes to sorafenib resistance in hepatocellular carcinoma via downregulating SPRED1
Wenliang Tan et al.
ANNALS OF TRANSLATIONAL MEDICINE (2021)
Single-cell long noncoding RNA (lncRNA) transcriptome implicates MALAT1 in triple-negative breast cancer (TNBC) resistance to neoadjuvant chemotherapy
Hibah Shaath et al.
CELL DEATH DISCOVERY (2021)
Antibody-Oligonucleotide Conjugates: A Twist to Antibody-Drug Conjugates
Julien Dugal-Tessier et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Long Non-coding RNA Expression Patterns in Stomach Adenocarcinoma Serve as an Indicator of Tumor Mutation Burden and Are Associated With Tumor-Infiltrating Lymphocytes and Microsatellite Instability
Dongdong Yang et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Exploration of the Associations of lncRNA Expression Patterns with Tumor Mutation Burden and Prognosis in Colon Cancer
Chengsheng Ding et al.
ONCOTARGETS AND THERAPY (2021)
Noncoding RNA therapeutics - challenges and potential solutions
Melanie Winkle et al.
NATURE REVIEWS DRUG DISCOVERY (2021)
The lncRNA Snhg1-Vps13D vesicle trafficking system promotes memory CD8 T cell establishment via regulating the dual effects of IL-7 signaling
Yanyan Zhang et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
miR-541 potentiates the response of human hepatocellular carcinoma to sorafenib treatment by inhibiting autophagy
Wen-Ping Xu et al.
GUT (2020)
Therapeutic potential of FLANC, a novel primate-specific long non-coding RNA in colorectal cancer
Martin Pichler et al.
GUT (2020)
Non-coding RNAs in GI cancers: from cancer hallmarks to clinical utility
Mihnea Paul Dragomir et al.
GUT (2020)
A Single Cell but Many Different Transcripts: A Journey into the World of Long Non-Coding RNAs
Enrico Alessio et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Entrectinib in ROS1 fusion-positive non-small-cell lung cancer: integrated analysis of three phase 1-2 trials
Alexander Drilon et al.
LANCET ONCOLOGY (2020)
Development of a long non-coding RNA signature for prediction of response to neoadjuvant chemoradiotherapy in locally advanced rectal adenocarcinoma
Lorenzo Ferrando et al.
PLOS ONE (2020)
Drug Resistance Biomarkers and Their Clinical Applications in Childhood Acute Lymphoblastic Leukemia
Narges Aberuyi et al.
FRONTIERS IN ONCOLOGY (2020)
Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours
David S. Hong et al.
BRITISH JOURNAL OF CANCER (2020)
Serum microRNAs as potential new biomarkers for cisplatin resistance in gastric cancer patients
Lei Jin et al.
PEERJ (2020)
Circular RNA circMET drives immunosuppression and anti-PD1 therapy resistance in hepatocellular carcinoma via the miR-30-5p/snail/DPP4 axis
Xiao-Yong Huang et al.
MOLECULAR CANCER (2020)
Low Expression of miR-20a-5p Predicts Benefit to Bevacizumab in Metastatic Breast Cancer Patients Treated within the TANIA Phase III Trial
Gabriel Rinnerthaler et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Perspective: The future of liquid biopsy
Catherine Alix-Panabieres
NATURE (2020)
MiR-145 in cancer therapy resistance and sensitivity: A comprehensive review
Wenxiu Xu et al.
CANCER SCIENCE (2020)
Prospective Assessment of Systemic MicroRNAs as Markers of Response to Neoadjuvant Chemotherapy in Breast Cancer
Andrew McGuire et al.
CANCERS (2020)
Circulating MicroRNAs and Extracellular Vesicle-Containing MicroRNAs as Response Biomarkers of Anti -programmed Cell Death Protein 1 or Programmed Death-Ligand 1 Therapy in NSCLC
Takehito Shukuya et al.
JOURNAL OF THORACIC ONCOLOGY (2020)
Cancer cell-derived exosomal circUHRF1 induces natural killer cell exhaustion and may cause resistance to anti-PD1 therapy in hepatocellular carcinoma
Peng-Fei Zhang et al.
MOLECULAR CANCER (2020)
Advances in oligonucleotide drug delivery
Thomas C. Roberts et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
The Long Noncoding RNA CCAT2 Induces Chromosomal Instability Through BOP1-AURKB Signaling
Baoqing Chen et al.
GASTROENTEROLOGY (2020)
Methylation-associated silencing of miR-193b improves the radiotherapy sensitivity of esophageal cancer cells by targeting cyclin D1 in areas with zinc deficiency
Jing Jin et al.
RADIOTHERAPY AND ONCOLOGY (2020)
Profiling the Non-genetic Origins of Cancer Drug Resistance with a Single-Cell Functional Genomics Approach Using Predictive Cell Dynamics
Mickael Meyer et al.
CELL SYSTEMS (2020)
The Value of Serum MicroRNA Expression Signature in Predicting Refractoriness to Bortezomib-Based Therapy in Multiple Myeloma Patients
Pawel Robak et al.
CANCERS (2020)
Circulating Non-coding RNAs in Renal Cell Carcinoma-Pathogenesis and Potential Implications as Clinical Biomarkers
Dominik A. Barth et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
miRNA-Based Feature Classifier Is Associated with Tumor Mutational Burden in Head and Neck Squamous Cell Carcinoma
Yu Xia et al.
BIOMED RESEARCH INTERNATIONAL (2020)
FuncPEP: A Database of Functional Peptides Encoded by Non-Coding RNAs
Mihnea P. Dragomir et al.
NON-CODING RNA (2020)
CircRNA-SORE mediates sorafenib resistance in hepatocellular carcinoma by stabilizing YBX1
Junjie Xu et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
miR-410 induces both epithelial-mesenchymal transition and radioresistance through activation of the PI3K/mTOR pathway in non-small cell lung cancer
Yue Yuan et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Association Between Polymorphisms in the Promoter Region of microRNA-34b/c and the Chemoradiotherapy Efficacy for Locally Advanced Esophageal Squamous Cell Carcinoma in Chinese Han Population
Jilisihan Bulibu et al.
PATHOLOGY & ONCOLOGY RESEARCH (2019)
MiR-20a-5p regulates gemcitabine chemosensitivity by targeting RRM2 in pancreatic cancer cells and serves as a predictor for gemcitabine-based chemotherapy
Huimin Lu et al.
BIOSCIENCE REPORTS (2019)
FDA Approval Summary: Pembrolizumab for the Treatment of Microsatellite Instability-High Solid Tumors
Leigh Marcus et al.
CLINICAL CANCER RESEARCH (2019)
Global Positioning System: Understanding Long Noncoding RNAs through Subcellular Localization
Joana Carlevaro-Fita et al.
MOLECULAR CELL (2019)
MSC-regulated lncRNA MACC1-AS1 promotes stemness and chemoresistance through fatty acid oxidation in gastric cancer
Wanming He et al.
ONCOGENE (2019)
Tumor mutational burden is predictive of response to immune checkpoint inhibitors in MSI-high metastatic colorectal cancer
A. B. Schrock et al.
ANNALS OF ONCOLOGY (2019)
Circular RNA AKT3 upregulates PIK3R1 to enhance cisplatin resistance in gastric cancer via miR-198 suppression
Xiaoxu Huang et al.
MOLECULAR CANCER (2019)
LncRNA Profile Study Reveals a Three-LncRNA Signature Associated With the Pathological Complete Response Following Neoadjuvant Chemotherapy in Breast Cancer
Ying Zeng et al.
FRONTIERS IN PHARMACOLOGY (2019)
Immunomodulatory MicroRNAs in cancer: targeting immune checkpoints and the tumor microenvironment
Hany A. Omar et al.
FEBS JOURNAL (2019)
miR-126-3p down-regulation contributes to dabrafenib acquired resistance in melanoma by up-regulating ADAM9 and VEGF-A
Simona Caporali et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Oncogenic lncRNA downregulates cancer cell antigen presentation and intrinsic tumor suppression
Qingsong Hu et al.
NATURE IMMUNOLOGY (2019)
MiRNA expression patterns are associated with tumor mutational burden in lung adenocarcinoma
Yufeng Lv et al.
ONCOIMMUNOLOGY (2019)
Intrinsic Resistance to EGFR-Tyrosine Kinase Inhibitors in EGFR-Mutant Non-Small Cell Lung Cancer: Differences and Similarities with Acquired Resistance
Eric Santoni-Rugiu et al.
CANCERS (2019)
Decrypting noncoding RNA interactions, structures, and functional networks
Muller Fabbri et al.
GENOME RESEARCH (2019)
The non-coding RNome after splenectomy
Mihnea P. Dragomir et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)
A novel tumor suppressor protein encoded by circular AKT3 RNA inhibits glioblastoma tumorigenicity by competing with active phosphoinositide-dependent Kinase-1
Xin Xia et al.
MOLECULAR CANCER (2019)
Noncoding RNAs in Extracellular Fluids as Cancer Biomarkers: The New Frontier of Liquid Biopsies
Barbara Pardini et al.
CANCERS (2019)
miRBase: from microRNA sequences to function
Ana Kozomara et al.
NUCLEIC ACIDS RESEARCH (2019)
MiRNA Delivery System Based on Stimuli-Responsive Gold Nanoparticle Aggregates for Multimodal Tumor Therapy
Xiangdong Wang et al.
ACS APPLIED BIO MATERIALS (2019)
Patisiran, an RNAi therapeutic for the treatment of hereditary transthyretin-mediated amyloidosis
Arnt Kristen et al.
NEURODEGENERATIVE DISEASE MANAGEMENT (2019)
pPB Peptide-Mediated siRNA-Loaded Stable Nucleic Acid Lipid Nanoparticles on Targeting Therapy of Hepatic Fibrosis
Zongxiang Jia et al.
MOLECULAR PHARMACEUTICS (2018)
Tumour heterogeneity and resistance to cancer therapies
Ibiayi Dagogo-Jack et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
CRISPR/Cas9-mediated noncoding RNA editing in human cancers
Jie Yang et al.
RNA BIOLOGY (2018)
Mechanisms of resistance to immune checkpoint inhibitors
Russell W. Jenkins et al.
BRITISH JOURNAL OF CANCER (2018)
Cancer-associated rs6983267 SNP and its accompanying long noncoding RNA &ITCCAT2&IT induce myeloid malignancies via unique SNP-specific RNA mutations
Maitri Y. Shah et al.
GENOME RESEARCH (2018)
Using microRNA Networks to Understand Cancer
Mihnea Dragomir et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Clinical utility of circulating non-coding RNAs - an update
Simone Anfossi et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Determinants and clinical implications of chromosomal instability in cancer
Laurent Sansregret et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Strategies to Tackle Radiation Resistance by Penetrating Cancer Stem Cell Line of Scrimmage
So-Yeon Park et al.
RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY (2018)
GalNAc-siRNA Conjugates: Leading the Way for Delivery of RNAi Therapeutics
Aaron D. Springer et al.
NUCLEIC ACID THERAPEUTICS (2018)
Exosomal lncRNAs as new players in cell-to-cell communication
Mihnea Dragomir et al.
TRANSLATIONAL CANCER RESEARCH (2018)
Key questions about the checkpoint blockade-are microRNAs an answer?
Mihnea Dragomir et al.
CANCER BIOLOGY & MEDICINE (2018)
Circular RNAs in Cancer - Lessons Learned From microRNAs
Mihnea Dragomir et al.
FRONTIERS IN ONCOLOGY (2018)
SnapShot: Unconventional miRNA functions
Mihnea Paul Dragomir et al.
CELL (2018)
Serum miR-518e-5p is a potential biomarker for secondary imatinib-resistant gastrointestinal stromal tumor
Youwei Kou et al.
JOURNAL OF BIOSCIENCES (2018)
Dynamics of circulating microRNAs as a novel indicator of clinical response to neoadjuvant chemotherapy in breast cancer
Wenjie Zhu et al.
CANCER MEDICINE (2018)
Synergistic Antitumor Effect on Bladder Cancer by Rational Combination of Programmed Cell Death 1 Blockade and CRISPR-Cas9-Mediated Long Non-Coding RNA Urothelial Carcinoma Associated 1 Knockout
Shuai Zhen et al.
HUMAN GENE THERAPY (2018)
Tumor-derived microRNAs induce myeloid suppressor cells and predict immunotherapy resistance in melanoma
Veronica Huber et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Comparative safety of immune checkpoint inhibitors in cancer: systematic review and network meta-analysis
Cheng Xu et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
miR-139-5p Modulates Radiotherapy Resistance in Breast Cancer by Repressing Multiple Gene Networks of DNA Repair and ROS Defense
Marina Pajic et al.
CANCER RESEARCH (2018)
Induction of tumor apoptosis through a circular RNA enhancing Foxo3 activity
William W. Du et al.
CELL DEATH AND DIFFERENTIATION (2017)
Noncoding RNAs and immune checkpoints-clinical implications as cancer therapeutics
Maria A. Smolle et al.
FEBS JOURNAL (2017)
MicroRNA Expression-Based Model Indicates Event-Free Survival in Pediatric Acute Myeloid Leukemia
Emilia L. Lim et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
iASPP induces EMT and cisplatin resistance in human cervical cancer through miR-20a-FBXL5/BTG3 signaling
Ying Xiong et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2017)
IncRNA MIR100HG-derived miR-100 and miR-125b mediate cetuximab resistance via Wnt/β-catenin signaling
Yuanyuan Lu et al.
NATURE MEDICINE (2017)
MEG3 is a prognostic factor for CRC and promotes chemosensitivity by enhancing oxaliplatin-induced cell apoptosis
Lixia Li et al.
ONCOLOGY REPORTS (2017)
New Dancing Couple: PD-L1 and MicroRNA
A. Grenda et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2017)
A promoter-proximal transcript targeted by genetic polymorphism controls E-cadherin silencing in human cancers
Giuseppina Pisignano et al.
NATURE COMMUNICATIONS (2017)
Molecular Mechanisms of Antisense Oligonucleotides
Stanley T. Crooke
NUCLEIC ACID THERAPEUTICS (2017)
Long noncoding RNA XIST is a prognostic factor in colorectal cancer and inhibits 5-fluorouracil-induced cell cytotoxicity through promoting thymidylate synthase expression
Yang Xiao et al.
ONCOTARGET (2017)
Long noncoding RNA expression signature to predict platinum-based chemotherapeutic sensitivity of ovarian cancer patients
Rong Liu et al.
SCIENTIFIC REPORTS (2017)
Long Noncoding RNAs as Biomarkers in Cancer
Luka Bolha et al.
DISEASE MARKERS (2017)
Hsa_circ_0020397 regulates colorectal cancer cell viability, apoptosis and invasion by promoting the expression of the miR-138 targets TERT and PD-L1
Xiu-li Zhang et al.
CELL BIOLOGY INTERNATIONAL (2017)
MicroRNA-21 contributes to the discrimination of chemoresistance in metastatic gastric cancer
Ming Qi et al.
CANCER BIOMARKERS (2017)
N-BLR, a primate-specific non-coding transcript leads to colorectal cancer invasion and migration
Isidore Rigoutsos et al.
GENOME BIOLOGY (2017)
Resistance is futile: overcoming resistance to targeted therapies in lung adenocarcinoma
Dana S. Neel et al.
NPJ PRECISION ONCOLOGY (2017)
MiR-138 exerts anti-glioma efficacy by targeting immune checkpoints
Jun Wei et al.
NEURO-ONCOLOGY (2016)
MiR-106a: Promising biomarker for cancer
Yao-Jie Pan et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
miR-126 Regulates Distinct Self-Renewal Outcomes in Normal and Malignant Hematopoietic Stem Cells
Eric R. Lechman et al.
CANCER CELL (2016)
Exosome-Transmitted lncARSR Promotes Sunitinib Resistance in Renal Cancer by Acting as a Competing Endogenous RNA
Le Qu et al.
CANCER CELL (2016)
MiR-20a-5p represses multi-drug resistance in osteosarcoma by targeting the KIF26B gene
Youguang Pu et al.
CANCER CELL INTERNATIONAL (2016)
Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: A review of the past decade
Zhaolin Chen et al.
CANCER LETTERS (2016)
Noncoding RNA NORAD Regulates Genomic Stability by Sequestering PUMILIO Proteins
Sungyul Lee et al.
CELL (2016)
Allele-Specific Reprogramming of Cancer Metabolism by the Long Non-coding RNA CCAT2
Roxana S. Redis et al.
MOLECULAR CELL (2016)
Endogenous microRNA sponges: evidence and controversy
Daniel W. Thomson et al.
NATURE REVIEWS GENETICS (2016)
Unique features of long non-coding RNA biogenesis and function
Jeffrey J. Quinn et al.
NATURE REVIEWS GENETICS (2016)
The biogenesis and emerging roles of circular RNAs
Ling-Ling Chen
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2016)
miR-625-3p regulates oxaliplatin resistance by targeting MAP2K6-p38 signalling in human colorectal adenocarcinoma cells
Mads Heilskov Rasmussen et al.
NATURE COMMUNICATIONS (2016)
Changes in circulating microRNA-126 during treatment with chemotherapy and bevacizumab predicts treatment response in patients with metastatic colorectal cancer
T. F. Hansen et al.
BRITISH JOURNAL OF CANCER (2015)
Potential molecular, cellular and microenvironmental mechanism of sorafenib resistance in hepatocellular carcinoma
Jiang Chen et al.
CANCER LETTERS (2015)
Myeloid Cells and Related Chronic Inflammatory Factors as Novel Predictive Markers in Melanoma Treatment with Ipilimumab
Christoffer Gebhardt et al.
CLINICAL CANCER RESEARCH (2015)
MiR-20a Induces Cell Radioresistance by Activating the PTEN/PI3K/Akt Signaling Pathway in Hepatocellular Carcinoma
Yuqin Zhang et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2015)
Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma
Dirk Schadendorf et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Small molecules targeting microRNA for cancer therapy: Promises and obstacles
Di Wen et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Analysis of 13 cell types reveals evidence for the expression of numerous novel primate- and tissue-specific microRNAs
Eric Londin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
MicroRNAs as Potential Biomarkers in Cancer: Opportunities and Challenges
Huiyin Lan et al.
BIOMED RESEARCH INTERNATIONAL (2015)
In Vitro Antiviral Activity and Preclinical and Clinical Resistance Profile of Miravirsen, a Novel Anti-Hepatitis C Virus Therapeutic Targeting the Human Factor miR-122
Soren Ottosen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Screening for Small-Molecule Modulators of Long Noncoding RNA-Protein Interactions Using AlphaScreen
Roya Pedram Fatemi et al.
JOURNAL OF BIOMOLECULAR SCREENING (2015)
The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence
Holly E. Barker et al.
NATURE REVIEWS CANCER (2015)
MicroRNA biogenesis pathways in cancer
Shuibin Lin et al.
NATURE REVIEWS CANCER (2015)
Exosomes A Novel Pathway of Local and Distant Intercellular Communication that Facilitates the Growth and Metastasis of Neoplastic Lesions
Huang-Ge Zhang et al.
AMERICAN JOURNAL OF PATHOLOGY (2014)
Circulating microRNA expressions in colorectal cancer as predictors of response to chemotherapy
Jian Zhang et al.
ANTI-CANCER DRUGS (2014)
Reduced Expression of miRNA-27a Modulates Cisplatin Resistance in Bladder Cancer by Targeting the Cystine/Glutamate Exchanger SLC7A11
Ross M. Drayton et al.
CLINICAL CANCER RESEARCH (2014)
Sunitinib objective response in metastatic renal cell carcinoma: Analysis of 1059 patients treated on clinical trials
A. M. Molina et al.
EUROPEAN JOURNAL OF CANCER (2014)
Designing a gold nanoparticle-based nanocarrier for microRNA transfection into the prostate and breast cancer cells
Asli Ekin et al.
JOURNAL OF GENE MEDICINE (2014)
Urinary PCA3 as a Predictor of Prostate Cancer in a Cohort of 3,073 Men Undergoing Initial Prostate Biopsy
K. Kent Chevli et al.
JOURNAL OF UROLOGY (2014)
Plasma microRNAs predicting clinical outcome in metastatic colorectal cancer patients receiving first-line oxaliplatin-based treatment
J. B. Kjersem et al.
MOLECULAR ONCOLOGY (2014)
MSC-derived exosomes: a novel tool to treat therapy-refractory graft-versus-host disease
L. Kordelas et al.
LEUKEMIA (2014)
Pulling the plug on a cancer cell by eliminating XIAP with AEG35156
Eric C. LaCasse
CANCER LETTERS (2013)
Increased expression of miR-126 and miR-10a predict prolonged relapse-free time of primary oestrogen receptor-positive breast cancer following tamoxifen treatment
Reiner Hoppe et al.
EUROPEAN JOURNAL OF CANCER (2013)
CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer
Hui Ling et al.
GENOME RESEARCH (2013)
Extracellular communication via microRNA: lipid particles have a new message
Katey J. Rayner et al.
JOURNAL OF LIPID RESEARCH (2013)
High expression of microRNA-625-3p is associated with poor response to first-line oxaliplatin based treatment of metastatic colorectal cancer
Mads H. Rasmussen et al.
MOLECULAR ONCOLOGY (2013)
Natural RNA circles function as efficient microRNA sponges
Thomas B. Hansen et al.
NATURE (2013)
Circular RNAs are a large class of animal RNAs with regulatory potency
Sebastian Memczak et al.
NATURE (2013)
Expression and regulation of intergenic long noncoding RNAs during T cell development and differentiation
Gangqing Hu et al.
NATURE IMMUNOLOGY (2013)
The role of microRNAs in cancers of the upper gastrointestinal tract
Shumei Song et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2013)
Cell-Type Specific Features of Circular RNA Expression
Julia Salzman et al.
PLOS GENETICS (2013)
Liposome: classification, preparation, and applications
Abolfazl Akbarzadeh et al.
NANOSCALE RESEARCH LETTERS (2013)
Centrosome dysfunction contributes to chromosome instability, chromoanagenesis, and genome reprogra in cancer
German A. Pihan
FRONTIERS IN ONCOLOGY (2013)
Lipid-based carriers of microRNAs and intercellular communication
Kasey C. Vickers et al.
CURRENT OPINION IN LIPIDOLOGY (2012)
The GENCODE v7 catalog of human long noncoding RNAs: Analysis of their gene structure, evolution, and expression
Thomas Derrien et al.
GENOME RESEARCH (2012)
Cancer stem cells and drug resistance: the potential of nanomedicine
Serguei Vinogradov et al.
NANOMEDICINE (2012)
An unconventional role for miRNA: let-7 activates Toll-like receptor 7 and causes neurodegeneration
Sabrina M. Lehmann et al.
NATURE NEUROSCIENCE (2012)
MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response
Muller Fabbri et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Overexpression of miR-200c Induces Chemoresistance in Esophageal Cancers Mediated Through Activation of the Akt Signaling Pathway
Rie Hamano et al.
CLINICAL CANCER RESEARCH (2011)
Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma
Jason D. Arroyo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Unidirectional transfer of microRNA-loaded exosomes from T cells to antigen-presenting cells
Maria Mittelbrunn et al.
NATURE COMMUNICATIONS (2011)
The Promise of MicroRNA Replacement Therapy
Andreas G. Bader et al.
CANCER RESEARCH (2010)
Stimulus-responsive macromolecules and nanoparticles for cancer drug delivery
Sarah R. MacEwan et al.
NANOMEDICINE (2010)
MicroRNA sponges: Progress and possibilities
Margaret S. Ebert et al.
RNA (2010)
Resistance to Targeted Therapies: Refining Anticancer Therapy in the Era of Molecular Oncology
Lee M. Ellis et al.
CLINICAL CANCER RESEARCH (2009)
Interspecies regulation of microRNAs and their targets
Misook Ha et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2008)
The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis
Shusheng Wang et al.
DEVELOPMENTAL CELL (2008)
Breast cancer patients with estrogen receptor-negative/progesterone receptor-positive tumors: being younger and getting less benefit from adjuvant tamoxifen treatment
Ke-da Yu et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2008)
Ultraconserved regions encoding ncRNAs are, altered in human leukemias and carcinomas
George A. Calin et al.
CANCER CELL (2007)
Short blocks from the noncoding parts of the human genome have instances within nearly all known genes and relate to biological processes
I Rigoutsos et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Rapid evolution of noncoding RNAs: lack of conservation does not mean lack of function
KC Pang et al.
TRENDS IN GENETICS (2006)
Silencing of microRNAs in vivo with 'antagomirs'
J Krützfeldt et al.
NATURE (2005)
Molecular mechanisms of drug resistance
DB Longley et al.
JOURNAL OF PATHOLOGY (2005)
MALAT-1, a novel noncoding RNA, and thymosin β4 predict metastasis and survival in early-stage non-small cell lung cancer
P Ji et al.
ONCOGENE (2003)
Role of microRNAs in plant and animal development
JC Carrington et al.
SCIENCE (2003)
Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia
GA Calin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Share Paper
